Dr. Srihari's scholarly focus is on improving the outcomes of early course schizophrenia spectrum disorders. His research interests span the translational continuum from studies of etiology and pathophysiology to interventions on clinical samples, to service level innovations. As Director of the STEP Program, he leads activities that connect this research to the missions of delivering a model service (the STEP Clinic), disseminating clinical best practices (via Learning Health Networks), education and workforce development and influencing policies that support the public health mission of early Intervention for schizophrenia spectrum disorders.
In his curricular work, he has led the development and implementation of an Evidence-Based Medicine (EBM) based approach to enabling psychiatrists in training to ask, access, appraise and apply the best available scientific evidence to their practice and to audit the health of the populations they are responsible for.
Dr. Srihari also consults with academic and non-academic healthcare systems that seek to initiate or refine early intervention services for recent onset or 'first-episode' psychosis.
|Stephen Fleck Award||Yale University Department of Psychiatry||2018|
|PRA Teaching Award||Yale Psychiatry Residents Association||2011|
|Model Curriculum in Evidence-Based Mental Health||American Association of Directors of Psychiatric Residency Training||2011|
|Chairman's Award||Yale University Department of Psychiatry||2007|
|Resident Teaching Award||Yale University Department of Psychiatry||2004|
|NIMH||Mental Health Services Research Study Section||2015 - 2018|